Phosphorylation of serine-504 of tNOX (ENOX2) modulates cell proliferation and migration in cancer cells

Experimental Cell Research

Volumn 318, Issue 14, 2012, Pages 1759-1766

  Zeng, Zih Ming ^a   Chuang, Show Mei ^a   Chang, Ting Chia ^a   Hong, Chen Wei ^a   Chou, Jou Chun ^a   Yang, Jaw Ji ^b   Chueh, Pin Ju ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Migration; Phosphorylation; Proliferation; Protein kinase C (PKC ); Tumor associated NADH oxidase (tNOX, ENOX2)

Indexed keywords

PROTEIN KINASE C DELTA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SERINE; TUMOR ASSOCIATED NADH OXIDASE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL FUNCTIONS; CANCER CELL; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN 3T3; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; MODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY;

EID: 84862885343     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2012.04.021     Document Type: Article

References (34)

1. Bruno M., Brightman A.O., Lawrence J., Werderitsh D., Morré D.M., Morré D.J. Stimulation of NADH oxidase activity from rat liver plasma membranes by growth factors and hormones is decreased or absent with hepatoma plasma membranes. Biochem. J. 1992, 284:625-628.
2. Chueh P.J. Cell membrane redox systems and transformation. Antioxid. Redox Signal. 2000, 2:177-187.
3. Chueh P.J., Kim C., Cho N., Morré D.M., Morré D.J. Molecular cloning and characterization of a tumor-associated, growth-related, and time-keeping hydroquinone (NADH) oxidase (tNOX) of the HeLa cell surface. Biochemistry 2002, 41:3732-3742.
4. Morré D.J. NADH oxidase: a multifunctional ectoprotein of the eukaryotic cell surface. Plasma Membrane Redox Systems and their Role in Biological Stress and Disease 1998, 121-156. Kluwer Academic Publishers, Dordrecht, The Netherlands. H. Asard, A. Bérczi, R. Caubergs (Eds.).
5. Morré D.J., Chueh P.J., Morré D.M. Capsaicin inhibits preferentially the NADH oxidase and growth of transformed cells in culture. Proc. Nat. Acad. Sci. U. S. A. 1995, 92:1831-1835.
6. Wang H.M., Chueh P.J., Chang S.P., Yang C.L., Shao K.N. Effect of capsaicin on tNOX (ENOX2) protein expression in stomach cancer cells. BioFactors 2009, 34:209-217.
7. Chen C.F., Huang S., Liu S.C., Chueh P.J. Effect of polyclonal antisera to recombinant tNOX protein on the growth of transformed cells. BioFactors 2006, 28:119-133.
8. Mao L.C., Wang H.M., Lin Y.Y., Chang T.K., Hsin Y.H., Chueh P.J. Stress-induced downregulation of tumor-associated NADH oxidase during apoptosis in transformed cells. FEBS Lett. 2008, 582:3445-3450.
9. Liu S.C., Yang J.J., Shao K.N., Chueh P.J. RNA interference targeting tNOX attenuates cell migration via a mechanism that involved membrane association of Rac. Biochem. Biophys. Res. Commun. 2008, 365:672-677.
10. Wang H.M., Chuang S.M., Su Y.C., Li Y.H., Chueh P.J. Down-regulation of tumor-associated NADH oxidase, tNOX (ENOX2), enhances capsaicin-induced inhibition of gastric cancer cell growth. Cell Biochem. Biophys. 2011, 61:355-366.
11. Chueh P.J., Morré D.J., Wilkinson F.E., Gibson J., Morré D.M. A 33.5kD heat- and protease-resistant NADH oxidase inhibited by capsaicin from sera of cancer patients. Arch. Biochem. Biophys. 1997, 342:38-47.
12. Morré D.J., Reust T. A circulating form of NADH oxidase activity responsive to the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl)urea (LY181984) specific to sera of cancer patients. J. Bioenerg. Biomembr. 1997, 29:281-289.
13. Morré D.J., Caldwell S., Mayorga A., Wu L.Y., Morré D.M. NADH oxidase activity from sera altered by capsaicin is widely distributed among cancer patients. Arch. Biochem. Biophys. 1997, 342:224-230.
14. Chueh P.J., Kim C., Cho N., Morré D.M., Morré D.J. Molecular cloning and characterization of a tumor-associated, growth-related, and time-keeping hydroquinone (NADH) oxidase (tNOX) of the HeLa cell surface. Biochemistry 2002, 41:3732-3741.
15. Chueh P.J., Morré D.M., Morré D.J. A site-directed mutagenesis analysis of tNOX functional domains. Biochim. Biophys. Acta 2002, 1594:74-83.
16. Morré D.J., Bridge A., Wu L.Y., Morré D.M. Preferential inhibition by (-)-epigallocatechin-3-gallate of the cell surface NADH oxidase and growth of transformed cells in culture. Biochem. Pharmacol. 2000, 60:937-946.
17. Morré D.J., Chueh P.J., Yagiz K., Balicki A., Kim C., Morré D.M. ECTO-NOX target for the anticancer isoflavene phenoxodiol. Oncol. Res. 2007, 16:299-312.
18. Chueh P.J., Wu L.Y., Morré D.M., Morré D.J. tNOX is both necessary and sufficient as a cellular target for the anticancer actions of capsaicin and the green tea catechin (-)-epigallocatechin-3-gallate. BioFactors 2004, 20:249-263.
19. Kuo Y.F., Su Y.Z., Tseng Y.H., Wang S.Y., Wang H.M., Chueh P.J., Flavokawain B. a novel chalcone from Alpinia pricei Hayata with potent apoptotic activity: Involvement of ROS and GADD153 upstream of mitochondria-dependent apoptosis in HCT116 cells. Free Radical Biol. Med. 2010, 49:214-226.
20. Chuang S.M., Wang I.C., Yang J.L. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium. Carcinogenesis 2000, 21:1423-1432.
21. Bird C., Kirstein S. Real-time, label-free monitoring of cellular invasion and migration with the xCELLigence system. Nat. Methods 2009, 6:v-vi. (Application Notes).
22. Ungefroren H., Sebens S., Groth S., Gieseler F., Fändrich F. Differential roles of Src in transforming growth factor-ß regulation of growth arrest, epithelial-to-mesenchymal transition and cell migration in pancreatic ductal adenocarcinoma cells. Int. J. Oncol. 2011, 38:797-805.
23. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992, 258:607-614.
24. Blobe G.C., Obeid L.M., Hannun Y.A. Regulation of protein kinase C and role in cancer biology. Cancer Metastasis Rev. 1994, 13:411-431.
25. Larsson C. Protein kinase C and the regulation of the actin cytoskeleton. Cell Signal. 2006, 18:276-284. (Review).
26. Yoshida K. PKCdelta signaling: mechanisms of DNA damage response and apoptosis. Cell Signal. 2007, 19:892-901.
27. McCracken M.A., Miraglia L.J., McKay R.A., Strobl J.S. Protein kinase C delta is a prosurvival factor in human breast tumor cell lines. Mol. Cancer Ther. 2003, 2:273-281.
28. Clark A.S., West K.A., Blumberg P.M., Dennis P.A. Altered protein kinase C (PKC) isoforms in non-small cell lung cancer cells: PKCdelta promotes cellular survival and chemotherapeutic resistance. Cancer Res. 2003, 63:780-786.
29. Chen C.L., Hsieh Y.T., Chen H.C. Phosphorylation of adducin by protein kinase Cδ promotes cell motility. J. Cell Sci. 2007, 122:513-523.
30. Yang S.F., Chen M.K., Hsieh Y.S., Chung T.T., Hsieh Y.H., Lin C.W., Su J.L., Tsai M.H., Tang C.H. Prostaglandin E2/EP1 signaling pathway enhances intercellular adhesion molecule 1 (ICAM-1) expression and cell motility in oral cancer cells. J. Biol. Chem. 2010, 285:29808-298160.
31. Iwabu A., Smith K., Allen F.D., Lauffenburger D.A., Wells A. Epidermal growth factor induces fibroblast contractility and motility via a protein kinase C delta-dependent pathway. J. Biol. Chem. 2004, 279:14551-14560.
32. Chen C.L., Chan P.C., Wang S.H., Pan Y.R., Chen H.C. Elevated expression of protein kinase Cδ induces cell scattering upon serum deprivation. J. Cell Sci. 2007, 123:2901-2913.
33. Lambeth J.D. NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 2004, 4:181-189.
34. Fontayne A., Dang P.M., Gougerot-Pocidalo M.A., El-Benna J. Phosphorylation of p47phox sites by PKC alpha, beta II, delta, and zeta: effect on binding to p22phox and on NADPH oxidase activation. Biochemistry 2002, 41:7743-7750.